Late-onset doxorubicin-induced congestive heart failure in an elderly cancer survivor: A case report.
Frontiers in cardiovascular medicine（2023）
Abstract
Late-onset DXR-induced cardiotoxicity is considered high-risk from 250 mg/m or higher. Elderly cancer survivors are at higher risk of cardiotoxicity than non-elderly cancer survivors and may require closer follow-up.
MoreTranslated text
Key words
doxorubicin,cardiotoxicity,onco-cardiology,cancer survivor,elderly,troponin I,global longitudinal strain
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined